Syros Reports Second Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. PRYMY
5. SKA-B
6. PBA
7. CCH:LN
8. META
9. BAJAJHFL:I
10. CCHGY

Go back to Syros Reports Second Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Tops Q2 EPS by 2c, Revenues Beat

August 6, 2020 7:50 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q2 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $3.19 million versus the consensus estimate of $1.9 million.

Despite the unforeseen challenges of recent months, our team at Syros has shown remarkable resiliency, continuing... More